Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 11 de 11
Filtrar
Más filtros

Bases de datos
País/Región como asunto
Tipo del documento
Intervalo de año de publicación
2.
Molecules ; 25(21)2020 Oct 22.
Artículo en Inglés | MEDLINE | ID: mdl-33105737

RESUMEN

Three pyrrole alkaloid derivatives were isolated from the edible mushroom Basidiomycetes-X (Echigoshirayukidake) by water extraction followed by ethyl acetate fractionation. The chemical structures determined by MS and NMR were 4-[2-formyl-5-(hydroxymethyl)-1H-pyrrol-1-yl] butanoic acid (compound I), 4-[2-formyl-5-(hydroxymethyl)-1H-pyrrol-1-yl] butanamide (compound II), and 5-(hydroxymethyl)-1H-pyrrole-2-carboxaldehyde (compound III). Compound I was found to be the major component, followed by compound II, and compound III was the minor component. The dry powder of Basidiomycetes-X contained approximately 825 µg g-1 compound I and 484 µg g-1 compound II. Compound II was found to be a novel pyrrole aldehyde homologue not previously reported and thus is a specific component of this mushroom.


Asunto(s)
Alcaloides/química , Basidiomycota/química , Mezclas Complejas/química , Suplementos Dietéticos/análisis , Pirroles/química , Acetatos/química , Aldehídos/química , Alcaloides/aislamiento & purificación , Mezclas Complejas/aislamiento & purificación , Cobre/química , Depuradores de Radicales Libres/química , Hierro/química , Espectroscopía de Resonancia Magnética , Espectrometría de Masas , Pirroles/aislamiento & purificación , Solventes/química
3.
J Tradit Complement Med ; 10(3): 245-251, 2020 May.
Artículo en Inglés | MEDLINE | ID: mdl-32670819

RESUMEN

Echigoshirayukidake is an edible mushroom found in Uonuma, Japan in 1994. It was assigned to a new species of Basidiomycetes (BDM-X) but is uniquely defect of forming bashidium. The high antioxidant activity and ß-glucan content of BDM-X suggest possible functions preventing type 2 diabetes. In the present study, anti-obesity and insulin resistance preventive functions of BDM-X were examined using genetically defined obese model rat, OLETF (Otsuka Long Evans Tokushima Fatty) by feeding regular diet with and without supplementation of 5% dried BDM-X powder (BDMP) for 15 weeks. BDMP supplementation to the diet significantly (p < 0.01) suppressed the body weight gain and also visceral fat accumulation during the feeding period compared to control diet. Simultaneously, the insulin resistance and the plasma levels of adiponectin and triglycerides were significantly (p = 0.003) ameliorated in the BDMP supplemented diet group. A statistical multivariate analysis showed the weight of three types of adipose tissue (epididymal, retroperirenal, and mesenteric fat) positively correlated with HOMA-IR (Homeostasis Model Assessment of Insulin Resistance), and negatively correlated with plasma adiponectin. These results indicate BDM-X is a new resource applicable to the functional foods or the complementary biomedicines to prevent metabolic syndromes leading to type 2 diabetes.

5.
Case Rep Rheumatol ; 2016: 9565427, 2016.
Artículo en Inglés | MEDLINE | ID: mdl-27672472

RESUMEN

A 34-year-old woman with primary antiphospholipid syndrome was admitted to the Gastroenterology Department of our hospital with fever, acute abdomen, watery diarrhea, and extremely high levels of inflammatory parameters. She had a history of left lower limb deep vein thrombosis and pulmonary embolism and was taking warfarin potassium. Acute gastroenteritis was suspected and an antibiotic was administered, but symptoms progressed. Abdominal ultrasonography showed occlusion of the left hepatic vein and the middle hepatic vein and her D-dimer level was high. Accordingly, Budd-Chiari syndrome was diagnosed and high-dose intravenous infusion of heparin was initiated. Her abdominal symptoms improved and the levels of inflammatory parameters and D-dimer decreased rapidly. It is known that antiphospholipid syndrome can be complicated by Budd-Chiari syndrome that usually occurs as subacute or chronic onset, but acute onset is rare. It is difficult to diagnose acute Budd-Chiari syndrome complicating antiphospholipid syndrome and this complication generally has a poor outcome. However, the present case can get early diagnosis and successful treatment with tight anticoagulant therapy.

6.
J Sci Food Agric ; 96(11): 3717-22, 2016 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-26676315

RESUMEN

BACKGROUND: Metabolic syndrome is a major risk factor for a variety of obesity-related diseases. Recently, the effects of functional foods have been investigated on lipid metabolism as a means to reduce lipid content in the blood, liver and adipose tissues associated with carnitine O-palmitoyltransferase (CPT) activity. Acanthopanax senticosus (Rupr. et Maxim) Harms (AS) is a medicinal herb possessing a wide spectra of functions including antioxidant, anti-inflammatory and anti-fatigue actions. Despite much research being focused on the cortical roots of AS, little information is available regarding its leaves, which are also expected to promote human health, for example by improving abnormal lipid metabolism. Here, we explored whether AS leaves affect lipid metabolism in mice fed a high-fat diet. RESULTS: The administration of AS to BALB/c mice fed a high-fat diet significantly decreased plasma triglycerides (TG). CPT activity in the liver of these mice was significantly enhanced by AS treatment. CONCLUSION: These findings indicate that AS leaves have the potential to alleviate increase in plasma TG levels due to high-fat diet intake in mice, possibly by increasing mitochondrial fatty acid ß-oxidation, especially via CPT activation. Consequently, daily intake of AS leaves could promote beneficial health effects including the prevention of metabolic syndrome. © 2015 Society of Chemical Industry.


Asunto(s)
Dieta Alta en Grasa , Eleutherococcus , Hiperlipidemias/metabolismo , Hipolipemiantes/farmacología , Hígado/efectos de los fármacos , Extractos Vegetales/farmacología , Triglicéridos/sangre , Animales , Carnitina O-Palmitoiltransferasa/metabolismo , Hiperlipidemias/sangre , Hiperlipidemias/etiología , Hiperlipidemias/prevención & control , Hipolipemiantes/uso terapéutico , Metabolismo de los Lípidos , Hígado/metabolismo , Masculino , Ratones Endogámicos BALB C , Mitocondrias/metabolismo , Fitoterapia , Extractos Vegetales/uso terapéutico , Hojas de la Planta
7.
Int Heart J ; 51(4): 238-41, 2010 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-20716839

RESUMEN

Tai Chi is a traditional Chinese conditioning exercise that has been used to integrate slow movements, controlled breathing, and mental concentration. The aim of the study was to determine whether Tai Chi training in addition to cardiac rehabilitation would result in a shift toward increased vagal activity of autonomic markers, such as baroreflex sensitivity (BRS) and heart rate variability (HRV). Twenty patients with coronary heart disease (CHD) (male/female: 13/7, mean age: 67.8 +/- 4.2 years, mean interval time after a coronary event: 19.8 months) completed this study. The Tai Chi group (n = 10) practiced supervised Tai Chi training once a week and home-based Tai Chi training three times a week together with conventional cardiac rehabilitation for one-year. The control group (n = 10) conducted the conventional cardiac rehabilitation only. BRS and HRV were evaluated at the baseline and after one-year of Tai Chi training. Compared with the controls, patients in the Tai Chi group showed statistically significant improvement in BRS (P = 0.036). These associations persisted after adjustment for age and other covariates. On the other hand, there were no significant trends seen in HRV. Additional Tai Chi training during cardiac rehabilitation may augment reflex vagal regulation, which adds importantly to knowledge of cardiac rehabilitation on autonomic regulation and clinical management of CHD.


Asunto(s)
Barorreflejo/fisiología , Enfermedad Coronaria/fisiopatología , Enfermedad Coronaria/rehabilitación , Frecuencia Cardíaca/fisiología , Taichi Chuan , Anciano , Sistema Nervioso Autónomo/fisiopatología , Presión Sanguínea/fisiología , Estudios de Cohortes , Femenino , Humanos , Masculino , Persona de Mediana Edad , Resultado del Tratamiento
8.
J Neuroimmune Pharmacol ; 4(1): 103-15, 2009 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-19034670

RESUMEN

OTK18 is a C2H2 type zinc finger protein involved in the regulation of HIV-1 replication in human mononuclear phagocytes. Previously, we reported OTK18 expression in brain perivascular macrophages but not in microglia in HIV encephalitis brain. We have cloned the OTK18 promoter region proximal to the transcriptional start site and determined the region responsible (-884/+1) for the basal transcriptional activity in a microglia cell line. Sequential deletion mutation analyses reveal three important response elements: Yingyang-1 (YY1; -805/-777), an HIV-1 response element for promoter activation; FoxD3 (-743/-725), a negative regulatory element; and Ets response element (-725/-707), a basal transcriptional activity response element. HIV-1 infection-induced upregulation of YY1 and c-Ets-1 protein, binding to the promoter region as determined by immunoblotting and chromatin immunoprecipitation and polymerase chain reaction (PCR) assays, and induction of YY1 was also observed in virus-infected monocyte-derived macrophages. Silencing of FoxD3 and YY1 in the cell line by small interfering RNA duplexes specific to these molecules significantly up- and downregulated basal OTK18 promoter activity in FoxD3 and YY1 response element-dependent manners, respectively. On the other hand, infection of primary cultured human microglia significantly reduced YY1 expression and induced FoxD3 as determined by immunoblotting and reverse transcription real-time PCR. These data suggest that HIV-1 induces OTK18 expression through a YY1-mediated manner in human macrophages, although its gene expression is suppressed by FoxD3 upregulation and YY1 downregulation in human microglia. This mechanism may explain the perivascular macrophage-specific expression of OTK18 in HIV encephalitis brains.


Asunto(s)
Proteínas de Unión al ADN/biosíntesis , Proteínas de Unión al ADN/genética , Factores de Transcripción Forkhead/fisiología , Infecciones por VIH/metabolismo , VIH-1 , Regiones Promotoras Genéticas/genética , Regiones Promotoras Genéticas/fisiología , Factores de Transcripción/biosíntesis , Factores de Transcripción/genética , Factor de Transcripción YY1/fisiología , Región de Flanqueo 5'/genética , Western Blotting , Inmunoprecipitación de Cromatina , Regulación de la Expresión Génica , Humanos , Luciferasas/genética , Macrófagos/metabolismo , Microglía/metabolismo , Proteína Proto-Oncogénica c-ets-1/fisiología , ARN Interferente Pequeño/genética , Elementos Reguladores de la Transcripción/genética , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa , Transfección
9.
Evid Based Complement Alternat Med ; 4(2): 195-202, 2007 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-17549236

RESUMEN

Distress-mediated tissue oxidative stress was examined as a model of sub-healthy condition defined in traditional Chinese medicine theory. Mice were subjected to psychologically stressful conditions by whiskers removal. Under this condition, spontaneous locomotive activity was significantly enhanced in the dark (P < 0.05 versus the control mice in three different movements), and granulocytes/lymphocytes balance shifted to granulocytes. At the same time, peroxynitrite level in blood plasma increased to approximately 180% from that of the control mice at 6 h after removal of the whiskers (P < 0.01), and was maintained even after 12 h. Both protein carbonyl formation and lipid peroxidation were significantly increased under this condition in brain, heart, liver and spleen at 6 h after removal of whiskers (P < 0.05 or P < 0.01), and these levels were maximized after 12 h (increased to 120-160%, P < 0.05 or P < 0.01). The oxidative tissue injuries observed at 12 h after the removal of the whiskers were effectively prevented by two traditional Chinese medicine formula: Shengmai San (SMS) and Ling Gui Zhu Gan Tang (LGZGT), when administered for 5 days before the removal of the whiskers. Therefore, this stress model is considered useful in assessing the preventive potential of antioxidants and antioxidant-based herbal mixtures in treating the pathophysiology associated with psychological or emotional distress.

10.
J Pharmacol Sci ; 104(1): 73-81, 2007 May.
Artículo en Inglés | MEDLINE | ID: mdl-17485916

RESUMEN

Neurodegenerative brain disorders such as Alzheimer's disease (AD) have been well investigated. However, significant methods for the treatment of the promotion and progression of AD are unavailable to date. Recent studies suggested that the redox imbalance and the accumulation of amyloid-beta (Abeta) peptide occurring in the brain of AD patients lead to oxidatively-induced apoptotic cell death. Here, we show the effects of Shengmai-san (SMS) on Abeta-induced cytotoxicity in PC-12 cells. SMS dose-dependently attenuated the cytotoxicity by Abeta incubation and also prevented the morphological damage in neurites of the PC-12 cells. Hemeoxygenase-1 and glutathione peroxidase-1 expressions were increased by SMS pretreatment. SMS decreased the phosphorylation level of c-jun amino-terminal kinase (JNK) and the activity of caspase-3, which were enhanced by Abeta incubation. Of importance, SMS treatment promoted neurite outgrowth. These data demonstrated dual roles of SMS in PC-12 cells. SMS prevents the apoptosis through the enhancement of anti-oxidant enzymes and inhibition of the JNK signaling pathway with the promotion of nerve cell maturation, thus suggesting benefits of SMS for the treating of neurodegenerative diseases. It may also be beneficial not only for the treatment of brain disorders but also for other diseases caused by oxidative stress.


Asunto(s)
Péptidos beta-Amiloides/toxicidad , Apoptosis/efectos de los fármacos , Medicamentos Herbarios Chinos/farmacología , Animales , Caspasa 3/metabolismo , Inhibidores de Caspasas , Supervivencia Celular/efectos de los fármacos , Cromatografía Líquida de Alta Presión , Ciclooctanos/química , Fragmentación del ADN/efectos de los fármacos , Dioxoles/química , Relación Dosis-Respuesta a Droga , Combinación de Medicamentos , Medicamentos Herbarios Chinos/química , Citometría de Flujo , Glutatión Peroxidasa/metabolismo , Hemo-Oxigenasa 1/metabolismo , Lignanos/química , MAP Quinasa Quinasa 4/metabolismo , Oxidación-Reducción/efectos de los fármacos , Células PC12 , Compuestos Policíclicos/química , Ratas , Factores de Tiempo , alfa-Tocoferol/farmacología , Proteína Letal Asociada a bcl/metabolismo , Glutatión Peroxidasa GPX1
11.
J Cardiovasc Pharmacol ; 42 Suppl 1: S93-7, 2003 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-14871037

RESUMEN

We investigated the contribution of the sympathetic nervous system (SNS) in maintaining blood pressure during administration of carvedilol in rats with dilated cardiomyopathy, and examined whether SNS hyperactivity induced by high-dose carvedilol is related to severity of heart failure. The hypotensive effect of carvedilol in rats with heart failure (Group F) was not significantly different to that in rats without (Group N). However, enhancement of the plasma norepinephrine concentration during carvedilol administration in Group F was higher than in Group N. The constitutive plasma NE concentration in Group F (562 +/- 146 pg/ml) was significantly higher than in Group N (203 +/- 55 pg/ml) and there was a significant positive correlation between the heart weight to body weight ratio and the plasma norepinephrine concentration. Values for the maximal effect of the norepinephrine hypertensive effect during norepinephrine intravenous infusion (Emax) decreased, and plasma norepinephrine concentrations at half-maximal effect of the norepinephrine hypertensive effect (EC50) increased in Group F compared with Group N (20.8 +/- 6.1 and 28.6 +/- 2.2 mmHg, and 4.5 +/- 1.9 and 1.5 +/- 0.2 ng/ml, respectively). These results suggested that the number of receptors (Emax) and sensitivity (EC50) to the norepinephrine hypertensive effect decreased in Group F. Changes in these parameters in Group F corresponded with the results of a beta-adrenergic receptor binding assay using I-125 iodocyanopindolol (Bmax = 32 +/- 4 in Group F and 53 +/- 2 fmol/mg protein in Group N). These results showed that the SNS (presynaptic) activity increased and the SNS receptor sensitivity in the blood pressure regulation system decreased in heart failure. Therefore, high-dose carvedilol treatment should be used with caution to avoid worsening heart failure.


Asunto(s)
Carbazoles/farmacocinética , Cardiomiopatía Dilatada/tratamiento farmacológico , Cardiomiopatía Dilatada/fisiopatología , Propanolaminas/farmacocinética , Sistema Nervioso Simpático/efectos de los fármacos , Sistema Nervioso Simpático/fisiología , Animales , Presión Sanguínea/efectos de los fármacos , Presión Sanguínea/fisiología , Peso Corporal , Carbazoles/administración & dosificación , Carbazoles/efectos adversos , Carvedilol , Relación Dosis-Respuesta a Droga , Epinefrina/sangre , Corazón/efectos de los fármacos , Corazón/fisiopatología , Frecuencia Cardíaca/efectos de los fármacos , Hipertensión/inducido químicamente , Hipotensión/inducido químicamente , Infusiones Intravenosas , Radioisótopos de Yodo , Masculino , Miocardio/patología , Norepinefrina/administración & dosificación , Norepinefrina/efectos adversos , Norepinefrina/sangre , Tamaño de los Órganos , Terminales Presinápticos/efectos de los fármacos , Terminales Presinápticos/fisiología , Propanolaminas/administración & dosificación , Propanolaminas/efectos adversos , Ensayo de Unión Radioligante , Ratas , Ratas Endogámicas Lew , Receptores Adrenérgicos beta 1/análisis , Receptores Adrenérgicos beta 1/efectos de los fármacos , Presión Ventricular/efectos de los fármacos , Presión Ventricular/fisiología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA